PsyRx CNS Bio-Tech Valuation Multiples

Discover revenue and EBITDA valuation multiples for PsyRx CNS Bio-Tech and similar public comparables like Ubiquitech Software, Strainsforpains, Dogecoin Cash, CordovaCann and more.

PsyRx CNS Bio-Tech Overview

About PsyRx CNS Bio-Tech

Cannabotech Ltd is engaged in the research and development of cannabis-based drugs. It is a biomedical company focused on the benefits of cannabinoids and medicinal mushrooms, applying the pure power of nature and science to health issues.


Founded

2018

HQ

Israel

Employees

21

Financials (FY)

Revenue: -
Net Income: -

Market Cap

$3M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

PsyRx CNS Bio-Tech Stock Performance

PsyRx CNS Bio-Tech has current market cap of $3M.

Market Cap Evolution


PsyRx CNS Bio-Tech's stock price is $0.24.

See more trading valuation data for PsyRx CNS Bio-Tech
Market CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3M-2.6%----

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

PsyRx CNS Bio-Tech Valuation Multiples

PsyRx CNS Bio-Tech Financial Valuation Multiples

As of September 17, 2026, PsyRx CNS Bio-Tech has market cap of $3M.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified PsyRx CNS Bio-Tech Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

PsyRx CNS Bio-Tech Competitors

PsyRx CNS Bio-Tech competitors include Ubiquitech Software, Strainsforpains, Dogecoin Cash, CordovaCann, IM Cannabis, Neon Bloom, RAMM Pharma, Weed, Pharmadrug and Indoor Harvest.

Most PsyRx CNS Bio-Tech public comparables operate across Cannabis, CannaTech and ViceTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Ubiquitech Software----
Strainsforpains----
Dogecoin Cash4.3x-(0.3x)-
CordovaCann0.7x-(12.6x)-
IM Cannabis0.2x-(1.9x)-
Neon Bloom0.5x-(0.6x)-
RAMM Pharma0.3x-(0.1x)-
Weed--(3.6x)-

This data is available for Pro users. Sign up to see all PsyRx CNS Bio-Tech competitors and their valuation data.

Start Free Trial

PsyRx CNS Bio-Tech VC Funding History

Before going public, PsyRx CNS Bio-Tech raised $14M in total equity funding, across 4 rounds.

Last private valuation of PsyRx CNS Bio-Tech was $26M, after raising $4M in June 2020.


PsyRx CNS Bio-Tech Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Jul-21Series ACybele Holdings$8M--
Jun-20Series A-$4M$26M-
Oct-19SeedFUNDit$2M--
Jan-19Pre-seed-$200K--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About PsyRx CNS Bio-Tech

Who are competitors of PsyRx CNS Bio-Tech?PsyRx CNS Bio-Tech main competitors include Ubiquitech Software, Strainsforpains, Dogecoin Cash, CordovaCann, IM Cannabis, Neon Bloom, RAMM Pharma, Weed, Pharmadrug, Indoor Harvest.

See public comps similar to PsyRx CNS Bio-Tech

Lists including PsyRx CNS Bio-Tech

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial